A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma
Authors
Keywords
-
Journal
Genome Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-12
DOI
10.1186/s13073-021-01010-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular determinants of response to PD-L1 blockade across tumor types
- (2021) Romain Banchereau et al. Nature Communications
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors
- (2020) Chao Cheng et al. INTERNATIONAL JOURNAL OF CANCER
- Programmed death ligand 1 protein expression, histological tumour differentiation and intratumoural heterogeneity in pulmonary adenocarcinoma
- (2020) Vladimír Tancoš et al. PATHOLOGY
- Prognostic value of KRAS/TP53/PIK3CA in non‑small cell lung cancer
- (2019) Jiayi Zhao et al. Oncology Letters
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
- (2019) Edward B. Garon et al. JOURNAL OF CLINICAL ONCOLOGY
- The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials
- (2019) Yangyang Xu et al. Translational Lung Cancer Research
- Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
- (2019) Ying Ding et al. Thoracic Cancer
- Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
- (2019) Lele Ye et al. Frontiers in Immunology
- FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management
- (2019) Isabelle Solassol et al. Biomolecules
- Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
- (2019) Xu Lei et al. CANCER LETTERS
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- ATR/CHK1 inhibitors and cancer therapy
- (2018) Zhaojun Qiu et al. RADIOTHERAPY AND ONCOLOGY
- Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy
- (2018) Frederick S. Varn et al. OncoImmunology
- Genomic characterization of six virus-associated cancers identifies changes in the tumor immune microenvironment and altered genetic programs
- (2018) Frederick S. Varn et al. CANCER RESEARCH
- Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma
- (2018) Heike Zabeck et al. PLoS One
- Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma
- (2017) Tomonari Kinoshita et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases
- (2017) Haojie Liu et al. OncoTargets and Therapy
- Increased p16 and p53 protein expression predicts poor prognosis in mucosal melanoma
- (2017) Hanbin Chen et al. Oncotarget
- Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials
- (2017) Qingyuan Huang et al. OncoImmunology
- Emerging roles ofRAC1in treating lung cancer patients
- (2016) T. Zou et al. CLINICAL GENETICS
- Toward a Shared Vision for Cancer Genomic Data
- (2016) Robert L. Grossman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification
- (2016) YU-JIE DONG et al. Oncology Letters
- Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles
- (2016) Frederick S. Varn et al. Nature Communications
- The CPTAC Data Portal: A Resource for Cancer Proteomics Research
- (2015) Nathan J. Edwards et al. JOURNAL OF PROTEOME RESEARCH
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma
- (2015) M B Schabath et al. ONCOGENE
- Non-small-cell lung cancer
- (2015) Cesare Gridelli et al. Nature Reviews Disease Primers
- Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
- (2015) Luisa Carbognin et al. PLoS One
- Prognostic Significance of Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients With Stage I Disease
- (2014) Kyuichi Kadota et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) Classification With Prognosis and EGFR Mutation in Lung Adenocarcinoma
- (2014) Naoki Yanagawa et al. ANNALS OF THORACIC SURGERY
- RAC1 inhibition as a therapeutic target for gefitinib-resistant non-small-cell lung cancer
- (2014) Naoki Kaneto et al. CANCER SCIENCE
- Battle Against Cancer: An Everlasting Saga of p53
- (2014) Qian Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Weighted Implementation of Suboptimal Paths (WISP): An Optimized Algorithm and Tool for Dynamical Network Analysis
- (2014) Adam T. Van Wart et al. Journal of Chemical Theory and Computation
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients—Based on a hospital study in China
- (2013) Z. Song et al. EJSO
- Roles of Chk1 in cell biology and cancer therapy
- (2013) Youwei Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Checkpoint kinase 1 protein expression indicates sensitization to therapy by checkpoint kinase 1 inhibition in non–small cell lung cancer
- (2013) Svetlana Grabauskiene et al. JOURNAL OF SURGICAL RESEARCH
- New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma
- (2013) Naoki Yanagawa et al. Journal of Thoracic Oncology
- The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations
- (2013) Koji Tsuta et al. LUNG CANCER
- An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
- (2012) L. A. Byers et al. CLINICAL CANCER RESEARCH
- The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
- (2012) Arne Warth et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients
- (2012) Akihiko Yoshizawa et al. Journal of Thoracic Oncology
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases
- (2012) Tetsukan Woo et al. PATHOLOGY INTERNATIONAL
- Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation
- (2012) Matthew D. Wilkerson et al. PLoS One
- Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas
- (2011) H. Okayama et al. CANCER RESEARCH
- Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification
- (2011) Prudence A. Russell et al. Journal of Thoracic Oncology
- Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases
- (2011) Akihiko Yoshizawa et al. MODERN PATHOLOGY
- Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
- (2010) Chang-Qi Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis
- (2009) Shuta Tomida et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of Recurrence-Free Survival in Postoperative Non-Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression
- (2008) E.-S. Lee et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started